Design, synthesis, and biological evaluation of novel iso-flavones derivatives as H3R antagonists

被引:6
作者
Xin, Jian [1 ,2 ]
Hu, Min [3 ]
Liu, Qian [3 ]
Zhang, Tian Tai [3 ]
Wang, Dong Mei [3 ]
Wu, Song [3 ]
机构
[1] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China
[2] Peking Union Med Coll, Beijing 100050, Peoples R China
[3] Inner Mongolia Med Univ, Sch Pharm, Hohhot, Peoples R China
关键词
H3R antagonist; iso-flavone; molecular docking; HISTAMINE H-3 RECEPTOR; INVERSE AGONIST; DISCOVERY; SIDE; BINDING; POTENT;
D O I
10.1080/14756366.2018.1509212
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Histamine H-3 receptor (H3R), a kind of G-protein coupled receptor (GPCR), is expressed mainly in the central nervous system (CNS) and plays a vital role in homoeostatic control. This study describes the design and synthesis of a series of novel H3R antagonists based on the iso-flavone scaffold. The results of the bioactivity evaluation show that four compounds (1c, 2c, 2h, and 2o) possess significant H3R inhibitory activities. Molecular docking indicates that a salt bridge, pi-pi T-shape interactions, and hydrophobic interaction all contribute to the interaction between compound 2h and H3R.
引用
收藏
页码:1545 / 1553
页数:9
相关论文
共 25 条
[1]   Pharmacoresistant temporal lobe epilepsy modifies histamine turnover and H3 receptor function in the human hippocampus and temporal neocortex [J].
Banuelos-Cabrera, Ivette ;
Cuellar-Herrera, Manola ;
Luisa Velasco, Ana ;
Velasco, Francisco ;
Alonso-Vanegas, Mario ;
Carmona, Francia ;
Guevara, Rosalinda ;
Arias-Montano, Jose-Antonio ;
Rocha, Luisa .
EPILEPSIA, 2016, 57 (04) :E76-E80
[2]   Histamine H3 Receptor as a Drug Discovery Target [J].
Berlin, Michael ;
Boyce, Christopher W. ;
Ruiz, Manuel de Lera .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (01) :26-53
[3]   Dibasic biphenyl H3 receptor antagonists: Steric tolerance for a lipophilic side chain [J].
Bordi, Fabrizio ;
Rivara, Silvia ;
Dallaturca, Elisa ;
Carmi, Caterina ;
Pala, Daniele ;
Lodola, Alessio ;
Vacondio, Federica ;
Flammini, Lisa ;
Bertoni, Simona ;
Ballabeni, Vigilio ;
Barocelli, Elisabetta ;
Mor, Marco .
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2012, 48 :214-230
[4]   The physiology of brain histamine [J].
Brown, RE ;
Stevens, DR ;
Haas, HL .
PROGRESS IN NEUROBIOLOGY, 2001, 63 (06) :637-672
[5]  
Delay-Goyet Philippe, 2016, Alzheimers Dement (N Y), V2, P267, DOI 10.1016/j.trci.2016.10.002
[6]   The other side of the histamine H3 receptor [J].
Ellenbroek, Bart A. ;
Ghiabi, Bibinaz .
TRENDS IN NEUROSCIENCES, 2014, 37 (04) :191-199
[7]   Discovery of novel isoflavone derivatives as AChE/BuChE dual-targeted inhibitors: synthesis, biological evaluation and molecular modelling [J].
Feng, Bo ;
Li, Xinpeng ;
Xia, Jie ;
Wu, Song .
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2017, 32 (01) :968-977
[8]   Ciproxifan, a histamine H3 receptor antagonist, reversibly inhibits monoamine oxidase A and B [J].
Hagenow, S. ;
Stasiak, A. ;
Ramsay, R. R. ;
Stark, H. .
SCIENTIFIC REPORTS, 2017, 7
[9]   Discovery and Characterization of 6-{4[3-(R)-2-Methylpyrrolidin-1-yl)propoxy]phenyl}-2H-pyridazin-3-one (CEP-26401, Irdabisant): A Potent, Selective Histamine H3 Receptor Inverse Agonist [J].
Hudkins, Robert L. ;
Raddatz, Rita ;
Tao, Ming ;
Mathiasen, Joanne R. ;
Aimone, Lisa D. ;
Becknell, Nadine C. ;
Prouty, Catherine P. ;
Knutsen, Lars J. S. ;
Yazdanian, Mehran ;
Moachon, Gilbert ;
Ator, Mark A. ;
Mallamo, John P. ;
Marino, Michael J. ;
Bacon, Edward R. ;
Williams, Michael .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (13) :4781-4792
[10]   JNJ10181457, a histamine H3 receptor inverse agonist, regulates in vivo microglial functions and improves depression-like behaviours in mice [J].
Iida, Tomomitsu ;
Yoshikawa, Takeo ;
Karpati, Aniko ;
Matsuzawa, Takuro ;
Kitano, Haruna ;
Mogi, Asuka ;
Harada, Ryuichi ;
Naganuma, Fumito ;
Nakamura, Tadaho ;
Yanai, Kazuhiko .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 488 (03) :534-540